Concordia CEO to step down following appointment of new successor

OAKVILLE, Ont. – Concordia International Corp. (TSX:CXR) says chief executive Mark Thompson will step down following the appointment of a successor.

Thompson founded the company in December 2012.

The Ontario-based specialty drug company says the search process for a new CEO is underway.

Concordia says Thompson will also step down from the board of directors where he serves as chairman.

Jordan Kupinsky, lead independent director of the company, says the change was a joint decision between Thompson and the company’s board.

Concordia recently closed a US$350-million debt offering and completed a strategic review of its business.